Demographic, Socio-economic, behavioral and clinical factors predicting virologic failure with generic fixed-dose combination antiretroviral therapy before universal health insurance coverage in Northern Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 40, Issue 1, 2009, Pages 71-82

  Tsuchiya, Naho ^a   Pathipvanich, Panita ^b   Yasuda, Tadashi ^c   Mukoyama, Yumi ^c   Rojanawiwat, Archawin ^d   Matsubayashi, Toru ^a   Saeng aroon, Siriphan ^d   Auwanit, Wattana ^d   Matsuyama, Akiko ^a   Sawanpanyalert, Pathom ^d   Ariyoshi, Koya ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b LAMPANG HOSPITAL   (Thailand)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 59149102249     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000; 14: 357-66.
2. Braitstein P, Brinkhof MWG, Dabis F, et al. Mortality of HIV-l-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006; 367: 817-214.
3. Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg DR. Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. Int J STD AIDS 2005; 16:38-41.
4. Calmy A, Pinoges L, Szumilin E, Zachariah R, Ford N, Ferradini L. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS 2006; 20: 1163-9.
5. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000; 30 (suppl 2): S171-6.
6. Colebunders R, Moses KR, Laurence J, et al. A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries. Lancet Infect Dis 2006; 6: 53-9.
7. Gallant JE. Strategies for long-term success in the treatment of HIV infection. JAMA 2000; 283: 1329-34.
8. Gordillo V del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999; 13: 1763-9.
9. Haubrich RH, Currier JS,Forthal DN,et al. A randomized study of the utility of human immunodeficiency virus RNA measurement for the management of antiretroviral therapy. Clin Infect Dis 2001; 33: 1060-8.
10. Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS 1999; 13: 1099-107.
11. Ivers LC, Kendrick D, Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis 2005; 41:217-24.
12. Kamkamidze G, Sullivan T, Charbonneau T. Occurrence of HIV-1 reverse transcriptase gene mutation at codon 215 in HIV-infected infants. J Clin Virol 2001; 22: 143-8.
13. Kent DM, McGrath D, Ioannidis JP, Bennish ML. Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda. Clin Infect Dis 2003; 37 (suppl 1): S13-24.
14. Laurent C, Kouanfack C, Koulla-Shiro S, et al. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet 2004; 364: 29-34.
15. Ledergerber B, Egger M, Opravil M, et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet 1999; 353: 863-8.
16. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001; 134: 968-77.
17. Lockman S, Shapiro RL, Smeaton LM, et al. Response to antiretroviral therapy after a single, peripartum dose of nevirapine. N Engl J Med 2007; 356: 135-47.
18. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med 1999; 131: 81-7.
19. Murray JS, Elashoff MR, Iacono-Connors LC, Cvetkovich TA, Struble KA. The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs. AIDS 1999; 13: 797-804.
20. Nicastri E, Angeletti C, Palmisano L, et al. Gender differences in clinical progression of HIV-l-infected individuals during long-term highly active antiretroviral therapy. AIDS 2005; 19: 577-83.
21. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133: 21-30.
22. Pathipvanich P, Ariyoshi K, Rojanawiwat A, et al. Survival benefit from non-highly active antiretroviral therapy in a resource-constrained setting. J Acauir Immune Defic Syndr 2003; 32: 157-60.
23. Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis 2003; 37: 1112-8.
24. Severe P, Leger P, Charles M, et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med 2005; 353: 2325-34.
25. UNAIDS/WHO. Country progress report -Thailand : Follow up to the declaration of commitment on HIV/AIDS (UNGASS). 2005. [Cited 2008 May 20]. Available from: URL: http://data.unaids.org/pub/Report/2006/2006-country- progress-report-thailand-en.pdf
26. UNAIDS/WHO. AIDS epidemic update: December 2006. [Cited 2008 May 20]. Available from: URL: http://data.unaids.org/pub/EpiReport/2006/2006-EpiUpdate- en.pdf
27. Weiser S, Wolfe W, Bangsberg DR, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr 2003; 34: 281-8.
28. WHO. Towards UNIVERSAL ACCESS Scaling up priority HIV/AIDS interventions in the health sector Progress Report, April 2007. [Cited 2008 May 20]. Available from: URL: http://www.who.int/hiv/mediacentre/ universal-access-progress- report-en.pdf